SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hui He, Ji-Ye Yin, Ya-Jing Xu, Xi Li, Yu Zhang, Zhuo-Gang Liu, Fan Zhou, Ming Zhai, Yan Li, Xiang-Ping Li, Ying Wang, Hong-Hao Zhou, Zhao-Qian Liu, Association of ABCB1 Polymorphisms With the Efficacy of Ondansetron on Chemotherapy-Induced Nausea and Vomiting, Clinical Therapeutics, 2014,

    CrossRef

  2. 2
    Marko Popovic, David G. Warr, Carlo DeAngelis, May Tsao, Kelvin K. W. Chan, Michael Poon, Cheryl Yip, Natalie Pulenzas, Henry Lam, Liying Zhang, Edward Chow, Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials, Supportive Care in Cancer, 2014, 22, 6, 1685

    CrossRef

  3. 3
    Aurora Mirabile, Luigi Celio, Michele Magni, Erminio Bonizzoni, Alessandro Massimo Gianni, Massimo Di Nicola, Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy, Future Oncology, 2014, 1

    CrossRef

  4. 4
    Su-Peng Yeh, Woei-Chung Lo, Ching-Yun Hsieh, Li-Yuan Bai, Ching-Chan Lin, Po-Han Lin, Chen-Yuan Lin, Yu-Min Liao, Chang-Fang Chiu, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation, Supportive Care in Cancer, 2014, 22, 5, 1199

    CrossRef

  5. 5
    Cheng-Wei Chou, Yeh-Ku Chen, Yuan-Bin Yu, Kuang-Hsi Chang, Wen-Li Hwang, Chieh-Lin Jerry Teng, Palonosetron versus first-generation 5-hydroxytryptamine type 3 receptor antagonists for emesis prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation, Annals of Hematology, 2014, 93, 7, 1225

    CrossRef

  6. 6
    Sheila A Doggrell, Jules C Hancox, Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia, Expert Opinion on Drug Safety, 2013, 12, 3, 421

    CrossRef

  7. 7
    Y. JIN, W. SUN, D. GU, J. YANG, Z. XU, J. CHEN, Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis, European Journal of Cancer Care, 2013, 22, 1
  8. 8
    Caroline Maltepe, Gideon Koren, Preemptive Treatment of Nausea and Vomiting of Pregnancy: Results of a Randomized Controlled Trial, Obstetrics and Gynecology International, 2013, 2013, 1

    CrossRef

  9. 9
    Patrick J. Stiff, Mary P. Fox-Geiman, Karen Kiley, Karen Rychlik, Mala Parthasarathy, Donna Fletcher-Gonzalez, Nancy Porter, Aileen Go, Scott E. Smith, Tulio E. Rodriguez, Prevention of Nausea and Vomiting Associated with Stem Cell Transplant: Results of a Prospective, Randomized Trial of Aprepitant Used with Highly Emetogenic Preparative Regimens, Biology of Blood and Marrow Transplantation, 2013, 19, 1, 49

    CrossRef

  10. 10
    Y. E. Moon, J. Joo, J. E. Kim, Y. Lee, Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study, British Journal of Anaesthesia, 2012, 108, 3, 417

    CrossRef

  11. 11
    Lee S. Schwartzberg, Peter Jacobs, Panagiota Matsouka, Wellington Azevedo, Antonio Pinto, The role of second-generation 5-HT3 receptor antagonists in managing chemotherapy-induced nausea and vomiting in hematological malignancies, Critical Reviews in Oncology/Hematology, 2012, 83, 1, 59

    CrossRef

  12. 12
    Corrado Blandizzi, Carmelo Scarpignato, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2012,

    CrossRef

  13. 13
    Lee Schwartzberg, James Jackson, Gagan Jain, Sanjeev Balu, Deborah Buchner, Impact of 5-HT3RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting, Expert Review of Pharmacoeconomics & Outcomes Research, 2011, 11, 4, 481

    CrossRef

  14. 14
    Chris Craver, Julie Gayle, Sanjeev Balu, Deborah Buchner, Palonosetron versus other 5-HT3receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States, Journal of Medical Economics, 2011, 14, 3, 341

    CrossRef